Dr. Angela Kealey

Specialty:

Cardiology

About The Speaker

Dr. Angela Kealey was raised in Ottawa, Ontario. She received a Bachelor of Science degree in Biology, specialized emphasis biomedical toxicology from the University of Guelph in 1997. She attended medical school at the University of Ottawa and received her medical degree summa cum laude in 2001. She then moved west for her internal medicine and cardiology training at the University of Calgary, where she joined the Faculty of Medicine in 2009.

 

She is a Clinical Assistant Professor, heads the Cardio-Obstetrics program and is the Cardiology site lead at the Foothills Medical Centre. She joined the Calgary Heart Centre in 2016. Dr. Kealey’s clinical practice and research interests are in the areas of heart disease in women, heart disease in pregnancy and general cardiology. She is actively involved in medical education and in the cardiac catheterization laboratory.

 

Outside of medicine, she enjoys spending time with her husband and two children, and is known to many as an avid baker.

TBA

Specialty:

TBA

About The Speaker

Speaker to be announced

CME Topics

Cardiology & TBA

Dr. Kealey -

• Chest pain and coronary artery disease in women
  • Recognize typical and atypical presentations of myocardial ischemia and acute coronary syndromes in women, including sex-related differences in the etiology and presentation of chest pain and coronary artery disease.
  • Identify women at increased risk for coronary artery disease and recognize the contribution of risk factors and conditions that may be particularly relevant to women.
  • Select appropriate diagnostic testing and referral strategies for suspected stable coronary artery disease.
  • Select appropriate pharmacological and non-pharmacological therapy for macrovascular atherosclerosis, small vessel disease, coronary vasospasm and spontaneous coronary artery dissection.

• Heart disease in pregnancy part 1: sometimes it’s just a flow murmur
  • Identify the physiological cardiovascular changes of pregnancy and distinguish expected pregnancy-related symptoms from features that warrant further cardiac investigation.
  • Evaluate common presentations such as dyspnea, chest pain, palpitations, edema, and syncope during pregnancy.
  • Apply a practical approach to the initial evaluation and management including appropriate use of ECG, echocardiography, laboratory testing, and specialist consultation.

• Heart disease in pregnancy part 2: when it’s more than just a flow murmur
  • Recognize common acquired cardiovascular conditions that may present during pregnancy, including arrhythmias, valvular heart disease, cardiomyopathies, and coronary artery disease.
  • Recognize red flags for significant cardiovascular disease in pregnant and postpartum patients and initiate appropriate assessment and referral.
  • Describe the principles of medication selection and risk–benefit assessment for commonly used cardiovascular therapies during pregnancy and breastfeeding.
  • Develop an appropriate plan for multidisciplinary care and postpartum follow-up for patients with acquired heart disease during pregnancy.

• Heart failure, aka pneumonia that doesn’t get better with two courses of antibiotics
  • Recognize the signs, symptoms, and common causes of heart failure.
  • Interpret key investigations used in the diagnosis and assessment of heart failure, including ECG, natriuretic peptides, echocardiography, and relevant laboratory testing.
  • Implement evidence-based pharmacologic and non-pharmacologic management of heart failure with reduced and preserved ejection fraction in the primary care setting.
  • Identify patients who require urgent assessment, specialist referral, or closer monitoring, and develop an appropriate follow-up strategy.

• Lipid management
  • Assess cardiovascular risk and identify patients who would benefit from lipid-lowering therapy for primary or secondary prevention.
  • Interpret lipid profiles in the context of overall cardiovascular risk, comorbidities, and clinical circumstances.
  • Select appropriate lipid-lowering therapies based on the patient's cardiovascular risk and treatment goals.
  • Address common barriers to lipid-lowering therapy, including statin intolerance, adherence, drug interactions, and patient concerns about adverse effects.

• I’ve got rhythm: Atrial fibrillation
  • Recognize common clinical presentations and risk factors for atrial fibrillation (AF), including when to suspect AF in primary care.
  • Apply an evidence-based approach to stroke and systemic embolism risk assessment and determine when anticoagulation is indicated.
  • Select appropriate rate-control, rhythm-control, and anticoagulation strategies based on patient characteristics, symptoms, comorbidities, and preferences.
  • Identify patients with AF who require referral or urgent assessment.

MORE CME Details Coming Soon!